Cannabis Stock Drops 1.59% Tuesday: Should You Buy Marimed Inc (MRMD)?

MRMD, a player in the cannabis market, is lower by 1.59% Tuesday as it underperforms the market as a whole. Marimed Inc (MRMD) is around the bottom of the Healthcare sector according to InvestorsObserver. MRMD received an overall rating of 19, which means that it scores higher than 19% of stocks. Additionally, Marimed Inc scored a 4 in the Healthcare sector, ranking it higher than 4% of stocks in that sector.

MRMD has an Overall Score of 19. Find out what this means to you and get the rest of the rankings on MRMD!

See Full MRMD Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 19 means the stock is more attractive than 19 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Marimed Inc Stock Today?

Marimed Inc (MRMD) stock is unmoved -1.59% while the S&P 500 has risen 0.17% as of 12:44 PM on Tuesday, Nov 7. MRMD is unmoved $0.00 from the previous closing price of $0.32 on volume of 440,429 shares. Over the past year the S&P 500 is up 14.88% while MRMD is lower by -39.22%. MRMD earned $0.02 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 20.64. Click Here to get the full Stock Report for Marimed Inc stock.